Cipher Pharmaceuticals Inc (PHE) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	12.83M	12.22M	12.50M	12.07M
Cost of goods sold	2.35M	2.30M	2.21M	2.37M
Cost of revenue	2.35M	2.30M	2.21M	2.37M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.71M	3.68M	2.90M	3.18M
Operating expense	5.51M	5.49M	4.70M	4.96M
Total operating expenses	7.86M	7.79M	6.91M	7.33M
Operating income	4.97M	4.43M	5.60M	4.73M
Other non operating income	-	-	-	-
EBT including unusual items	4.26M	4.61M	4.95M	3.64M
EBT excluding unusual items	4.13M	4.84M	4.89M	3.90M
Income tax expense	-1.24M	-8.70M	-1.21M	-369.00K
Effective tax rate	-29.19%	-188.55%	-24.53%	-10.13%
Other operating expenses	-	-	-	-
Net income	5.50M	13.31M	6.16M	4.01M
Net profit margin	42.87%	108.95%	49.28%	33.26%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	15.00K
Interest expense	-241.00K	-109.00K	-51.00K	-
Net interest expenses	-241.00K	-109.00K	-51.00K	15.00K
Depreciation and amortization charges	1.80M	1.81M	1.81M	1.78M
EBITDA	6.77M	5.95M	7.32M	6.44M
Gain or loss from assets sale	-	-130.00K	-57.00K	-

Finance